About Recursion Pharmaceuticals
Recursion Pharmaceuticals is a company based in New York (United States) founded in 2013. Recursion Pharmaceuticals has raised $456.66 million across 21 funding rounds from investors including Nvidia, Intermountain Healthcare and Bayer. Recursion Pharmaceuticals has completed 4 acquisitions, including Cyclica, Exscientia and Valence Labs. Recursion Pharmaceuticals offers products and services including BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform. Recursion Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, BridgeBio, Moderna, C4 Therapeutics and Spark Therapeutics, among others.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Recursion Pharmaceuticals, Inc.
-
Annual Revenue
$58.84 M (USD)32as on Dec 31, 2024
-
Net Profit
-$463.66 M (USD)-41.33as on Dec 31, 2024
-
EBITDA
-$442.51 M (USD)-39.33as on Dec 31, 2024
-
Total Equity Funding
$456.66 M (USD)
in 21 rounds
-
Latest Funding Round
$6 M (USD), Seed
Feb 29, 2024
-
Investors
Nvidia
& 34 more
-
Employee Count
Not available
-
Investments & Acquisitions
Cyclica
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Recursion Pharmaceuticals
Recursion Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol RXRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Recursion Pharmaceuticals
Recursion Pharmaceuticals offers a comprehensive portfolio of products and services, including BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform.
Supercomputer for processing large-scale biological and chemical data.
AI agent for drug discovery processes and data analysis.
Integrated platform for AI-enabled gene and compound profiling.
People of Recursion Pharmaceuticals
Unlock access to complete
Unlock access to complete
Leadership Team
32 people
Data Analysis and Operations Team
30 people
Software Development Team
21 people
Senior Team
12 people
Product Management Team
11 people
Board Team
8 people
Operations Team
7 people
Finance and Accounting
6 people
Unlock access to complete
Funding Insights of Recursion Pharmaceuticals
Recursion Pharmaceuticals has successfully raised a total of $456.66M across 21 strategic funding rounds. The most recent funding activity was a Seed round of $6 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Recursion Pharmaceuticals
Recursion Pharmaceuticals has secured backing from 35 investors, including institutional and venture fund investors. Prominent investors backing the company include Nvidia, Intermountain Healthcare and Bayer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors by Kinnevik.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life sciences sector
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked |
Investor details for Recursion Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Recursion Pharmaceuticals
Recursion Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cyclica, Exscientia and Valence Labs.
Investment portfolio details for Recursion Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Research and productization engine within Recursion that focuses on advancing the frontier of AI in drug discovery
|
Locked | Locked | 2017 | Locked | |
|
Provider of living informatics platform for preclinical in vivo drug research
|
Locked | Locked | 2013 | Locked | |
|
AI-driven drug discovery and precision medicine solutions are provided.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Recursion Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Recursion Pharmaceuticals
Detailed financials for Recursion Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Recursion Pharmaceuticals Comparisons
Peer comparison for Recursion Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Recursion Pharmaceuticals
Recursion Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, BridgeBio, Moderna, C4 Therapeutics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
Detailed competitors of Recursion Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Recursion Pharmaceuticals
Complete news archive for Recursion Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Recursion Pharmaceuticals
Recursion Pharmaceuticals was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Recursion Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.
Recursion Pharmaceuticals is a funded company, having raised a total of $456.66M across 21 funding rounds to date.
Annual revenue of Recursion Pharmaceuticals is $58.84M as on Dec 31, 2024.
Recursion Pharmaceuticals was founded in 2013 and is headquartered in New York, United States. Operations center on biotechnology, where an AI platform is applied to drug discovery and development. Biological and chemical datasets are analyzed alongside machine learning models and a supercomputer to identify targets and design molecules. Emphasis is given to conditions with unmet needs, including cancers and rare diseases. Strategic partnerships are pursued to broaden therapeutic applications.
Recursion Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
Recursion Pharmaceuticals offers BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform.
Yes, Recursion Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol RXRX.
Recursion Pharmaceuticals has made 4 acquisitions, including Cyclica, Exscientia, and Valence Labs.
Recursion Pharmaceuticals has 35 investors. Key investors include Nvidia, Intermountain Healthcare, Bayer, NIH, and Square 1 Bank.
The ticker symbol of Recursion Pharmaceuticals is RXRX on NASDAQ.